Identification of prognostic alternative splicing signatures in hepatitis B or/and C viruses related hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of prognostic alternative splicing signatures in hepatitis B or/and C viruses related hepatocellular carcinoma

Published:2020-09 Issue:5 Volume:112 Page:3396-3406
ISSN:0888-7543
Container-title:Genomics
language:en
Short-container-title:Genomics

Author:

Cai Ying,Xia Jie,Wang Na,Zhou Hengyu

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Chongqing Basic and Frontier Research Project

Science and Technology Planning Project of Yuzhong District of Chongqing city

Publisher

Elsevier BV

Subject

Genetics

Reference53 articles.

1. Alternative splicing as a regulator of development and tissue identity;Baralle;Nat. Rev. Mol. Cell Biol.,2017

2. Mechanisms and regulation of alternative pre-mRNA splicing;Lee;Annu. Rev. Biochem.,2015

3. The functional impact of alternative splicing in Cancer;Climente-Gonzalez;Cell Rep.,2017

4. Therapeutic applications of targeted alternative splicing to Cancer treatment;Lin;Int. J. Mol. Sci.,2017

5. Expansion of the eukaryotic proteome by alternative splicing;Nilsen;Nature,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated pan-cancer analysis reveals the immunological and prognostic potential of RBFOX2 in human tumors;Frontiers in Pharmacology;2024-05-31

2. Virus–Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays;Viruses;2023-12-12

3. SARS-CoV-2 selectively induces the expression of unproductive splicing isoforms of interferon, class I MHC and splicing machinery genes;2023-04-13

4. A novel 16-gene alternative mRNA splicing signature predicts tumor relapse and indicates immune activity in stage I–III hepatocellular carcinoma;Frontiers in Pharmacology;2022-09-06

5. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data;Frontiers in Oncology;2021-10-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3